OZEMPIC is not recommended as the first choice of medicine for treating diabetes
What symptoms should patients watch for
This is why people can take Vitamin D supplements and yet still show up low on blood tests
Initial Combination Therapy with Metformin A total of 1091 patients with type 2 diabetes and inadequate glycemic control on diet and exercise participated in a 24-week, randomized, double-blind, placebo-controlled factorial study designed to assess the efficacy of sitagliptin as initial therapy in combination with metformin
Nodoubling doses increases nausea, vomiting, and GI discomfort without improving weight loss and can be unsafe
Finally, report any adverse effects, including taste disturbances, through the MHRA Yellow Card Scheme (www.mhra.gov.uk/yellowcard)